Back to search results
NCT07102849

Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study

Enrolling by Invitation
Not specifiedAges 2+Observational
National Heart, Lung, and Blood Institute (NHLBI)
~1,400 participants
Updated 2025-12-22 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Detection of molecular aberrations in marrow failure
Measured over baseline

Conditions

Bone Marrow Failure Disorders
VEXAS Syndrome
Hemoglobinurea, Paroxysmal
Myelodysplastic Syndromes
Bone Marrow Diseases

Explore related trials

Aplastic AnemiaCytopenia of Undetermined OriginMyelodysplastic SyndromePancytopeniaParoxysmal Nocturnal HemoglobinuriaPure Red Cell AplasiaT-Cell Large Granular Lymphocyte LeukemiaVEXAS Syndrome

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Bhavisha A Patel, M.D. · PRINCIPAL_INVESTIGATOR · National Heart, Lung, and Blood Institute (NHLBI)

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Detection of molecular aberrations in marrow failurebaseline

    To characterize the molecular aberrations in marrow failure and to understand how clonality, epigenetics, and proteomics contribute to hematopoiesis over the course of disease using high resolution multi-omics characterization of HSPC, immune cells and other cellular composition in peripheral blood and bone marrow samples.